Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 or older at the time of signing the consent form
- People diagnosed with a specific type of early breast cancer (hormone receptor-positive, HER2-negative) who are being treated with a prescribed oral medication called abemaciclib alongside hormone-based therapy, where that treatment started no more than 28 days ago
- People whose abemaciclib treatment follows the official prescribing guidelines and their treatment centre's standard medical practice
- People who have given their informed consent before any study activities begin
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who are pregnant or currently breastfeeding
- People for whom abemaciclib is medically unsuitable according to the official prescribing guidelines
- People whose treating doctor considers them ineligible due to serious other health conditions, unavailability, or any other relevant reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter A. Fasching, Prof. Dr. med., Department of Obstetrics and Gynaecology, Uniklinikum Erlangen
Phone: +49 15739466438
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to discontinuation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.